Paul Hooper floating a GBM scorpion toxin drug, this morning.
Its just entered an initial Phase 1 trial. This particular scorpion toxin drug has been around since 2001 - moving from periodic pre clinic work in Beijing to the USA. ...now landed in Aust.
Up to a cap of $130m this morning.....on nearly 20 m shares traded.
In one Phase 1 trial - as of very recently......But no - our management doing a great job.
Weak investors here - look at yourself in the mirror, and do something about it - like talking to the CEO about the situation.
- Forums
- ASX - By Stock
- KZA
- Kazia Share Price
Kazia Share Price, page-377
-
- There are more pages in this discussion • 415 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online